Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Amandeep Singh, Manik Aggarwal, Rajat Garg, Tyler Stevens & Prabhleen Chahal. (2022) Post-pancreatitis diabetes mellitus: insight on optimal management with nutrition and lifestyle approaches. Annals of Medicine 54:1, pages 1776-1786.
Read now
Read now
Giuseppe Derosa, Angela D’Angelo, Davide Romano & Pamela Maffioli. (2017) Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes. Drug Design, Development and Therapy 11, pages 1481-1488.
Read now
Read now
Tongzhi Wu, Michael Horowitz & Christopher K. Rayner. (2017) New insights into the anti-diabetic actions of metformin: from the liver to the gut. Expert Review of Gastroenterology & Hepatology 11:2, pages 157-166.
Read now
Read now
André J. Scheen. (2016) Will delayed release metformin provide better management of diabetes type 2?. Expert Opinion on Pharmacotherapy 17:5, pages 627-630.
Read now
Read now
Articles from other publishers (43)
Martin Haluzík, Iva Jakubíková, Michaela Kudláčková & Luděk Horváth. (2023) Current options for the treatment of obesity. Medicína pro praxi 20:4, pages 230-234.
Crossref
Crossref
Pasquale Mone, Giuseppe Martinelli, Angela Lucariello, Anna Luisa Leo, Anna Marro, Stefano De Gennaro, Stefania Marzocco, Divina Moriello, Salvatore Frullone, Luigi Cobellis & Gaetano Santulli. (2023) Extended-release metformin improves cognitive impairment in frail older women with hypertension and diabetes: preliminary results from the LEOPARDESS Study. Cardiovascular Diabetology 22:1.
Crossref
Crossref
Mingchao Yu, Meidai Liang, Qi An, Wenwen Wang, Baoxi Zhang, Shiying Yang, Jian Zhou, Xiuying Yang, Dezhi Yang, Li Zhang, Guanhua Du & Yang Lu. (2023) Versatile Solid Modifications of Multicomponent Pharmaceutical Salts: Novel Metformin–Rhein Salts Based on Advantage Complementary Strategy Design. Pharmaceutics 15:4, pages 1196.
Crossref
Crossref
Isma Haq, Alvaro Garcia Cruz, Sabrina Di Masi, Todd Cowen, Natalie S. Allcock, Cosimino Malitesta, Adnan Mujahid, Tajamal Hussain, Elena Piletska & Sergey A. Piletsky. (2023) Smart nano-actuators for electrochemical sensing of Metformin in human plasma. Sensors and Actuators B: Chemical 376, pages 132928.
Crossref
Crossref
Andrew P. Demidowich, Kristine Batty & Mihail Zilbermint. (2022) Instituting a Successful Discharge Plan for Patients With Type 2 Diabetes: Challenges and Solutions. Diabetes Spectrum 35:4, pages 440-451.
Crossref
Crossref
Mauricio Baeza, Gustavo Sáenz-Ravello & Cristóbal Cuadrado. (2022) Detección de Nuevas Tecnologías Sanitarias Para Mejorar el Control Metabólico de Pacientes Con Diabetes Tipo 2 Atendidos en el Programa de Salud Cardiovascular de Chile. Value in Health Regional Issues 31, pages 81-92.
Crossref
Crossref
Melissa Jones, Corina Mihaela Ionescu, Daniel Walker, Susbin Raj Wagle, Bozica Kovacevic, Jacqueline Chester, Thomas Foster, Edan Johnston, Jafri Kuthubutheen, Daniel Brown, Marcus D. Atlas, Momir Mikov, Armin Mooranian & Hani Al-Salami. (2022) Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions. International Journal of Molecular Sciences 23:2, pages 836.
Crossref
Crossref
Jean‐Daniel Lalau, Youssef Bennis, Abdallah Al‐Salameh, Anne‐Sophie Hurtel‐Lemaire & Salha Fendri. (2021)
Pharmacodynamics and pharmacokinetics of extended‐release metformin in patients with type
2
diabetes and chronic kidney disease stage
3B
. Diabetes, Obesity and Metabolism 24:1, pages 166-170.
Crossref
Crossref
Adrian Po Zhu Li & Dulmini Kariyawasam. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
225
243
.
Dalal Kojok, Ghina Ghazeeri & Johnny T. Awwad. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
233
253
.
Jane L. Tarry-Adkins, Imogen D. Grant, Susan E. Ozanne, Rebecca M. Reynolds & Catherine E. Aiken. (2021) Efficacy and Side Effect Profile of Different Formulations of Metformin: A Systematic Review and Meta-Analysis. Diabetes Therapy 12:7, pages 1901-1914.
Crossref
Crossref
Amna Younas, Junaid Riaz, Tamoor Chughtai, Hamza Maqsood, Shifa Younus, Muhammad Qasim, Muhammad Saim, Shaheryar Qazi, Muhammad Khaliq & Mahnoor Fatima. (2021) Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New-Onset Type 2 Diabetes Mellitus. Cureus.
Crossref
Crossref
Hua Nian, Xu Wan, Jing Ma, Fu Jie & Bin Wu. (2020) Economic evaluation of dapagliflozin versus metformin in Chinese patients whose diabetes is inadequately controlled with diet and exercise. Cost Effectiveness and Resource Allocation 18:1.
Crossref
Crossref
Giuseppe Derosa, Rodolfo Rivera, Angela D'Angelo & Pamela Maffioli. (2020) Metformin: From Immediate Release to Extended Release Formula, Effectiveness, And Safety in Patients With Chronic Kidney Disease. EMJ Diabetes, pages 70-78.
Crossref
Crossref
Selman KESİCİ & Benan BAYRAKÇI. (2020) Metformin Intoxications Requiring Admission to the Pediatric Intensive Care Unit. Turkish Journal of Pediatric Disease, pages 1-5.
Crossref
Crossref
Kristy Iglay, Baanie Sawhney, Alex Z. Fu, Gail Fernandes, Michael F. Crutchlow, Swapnil Rajpathak & Kamlesh Khunti. (2019) Dose distribution and up‐titration patterns of metformin monotherapy in patients with type 2 diabetes. Endocrinology, Diabetes & Metabolism 3:1.
Crossref
Crossref
Beth C. Bock, Shira I. Dunsiger, Wen-Chih Wu, Joseph T. Ciccolo, Eva R. Serber, Ryan Lantini & Bess H. Marcus. (2019) Reduction in HbA1c with Exercise videogames among participants with elevated HbA1c: Secondary analysis of the Wii Heart Fitness trial. Diabetes Research and Clinical Practice 154, pages 35-42.
Crossref
Crossref
Paulina Cybulska & Mario M. LeitaoJrJr. 2019. Fundamentals of Cancer Prevention. Fundamentals of Cancer Prevention
653
676
.
Mariël F. van Stee, Albert A. de Graaf & Albert K. Groen. (2018) Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy. Cardiovascular Diabetology 17:1.
Crossref
Crossref
Jung Hyun Lee, Jordan B. Jahrling, Larry Denner & Kelly T. Dineley. (2018) Targeting Insulin for Alzheimer’s Disease: Mechanisms, Status and Potential Directions. Journal of Alzheimer's Disease 64:s1, pages S427-S453.
Crossref
Crossref
Lorraine Lipscombe, Gillian Booth, Sonia Butalia, Kaberi Dasgupta, Dean T. Eurich, Ronald Goldenberg, Nadia Khan, Lori MacCallum, Baiju R. Shah & Scot Simpson. (2018) Pharmacologic Glycemic Management of Type 2 Diabetes in Adults. Canadian Journal of Diabetes 42, pages S88-S103.
Crossref
Crossref
Lyudmila A. Ruyatkina & Dmitriy S. Ruyatkin. (2017) Multidimensional effects of metformin in patients with type 2 diabetes. Diabetes mellitus 20:3, pages 210-219.
Crossref
Crossref
Silvio E. Inzucchi. (2017) Is It Time to Change the Type 2 Diabetes Treatment Paradigm? No! Metformin Should Remain the Foundation Therapy for Type 2 Diabetes. Diabetes Care 40:8, pages 1128-1132.
Crossref
Crossref
M P van der Aa, M A J Elst, E M W van de Garde, E G A H van Mil, C A J Knibbe & M M J van der Vorst. (2016) Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial. Nutrition & Diabetes 6:8, pages e228-e228.
Crossref
Crossref
Mohamad S. Alhadramy. (2016) Diabetes and oral therapies. Journal of Taibah University Medical Sciences 11:4, pages 317-329.
Crossref
Crossref
José A. Luchsinger, Thania Perez, Helena Chang, Pankaj Mehta, Jason Steffener, Gnanavalli Pradabhan, Masanori Ichise, Jennifer Manly, Davangere P. Devanand & Emilia Bagiella. (2016) Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial. Journal of Alzheimer's Disease 51:2, pages 501-514.
Crossref
Crossref
Kathleen M. Dungan. 2016. Endocrinology: Adult and Pediatric. Endocrinology: Adult and Pediatric
839
853.e2
.
Amjad Abualsuod, Joshua J. Rutland, Thomas E. Watts, Summit Pandat, Robert Delongchamp & Jawahar L. Mehta. (2015) The Effect of Metformin Use on Left Ventricular Ejection Fraction and Mortality Post-Myocardial Infarction. Cardiovascular Drugs and Therapy 29:3, pages 265-275.
Crossref
Crossref
Francisco J. Pasquel, Ziad Hinedi, Guillermo E. Umpierrez, Robin Klein, Adaeze Adigweme, Richard Coralli, Juan L. Pimentel & Fred A. Lopez. (2015) Metformin-Associated Lactic Acidosis. The American Journal of the Medical Sciences 349:3, pages 263-267.
Crossref
Crossref
Kelly T. Dineley, Jordan B. Jahrling & Larry Denner. (2014) Insulin resistance in Alzheimer's disease. Neurobiology of Disease 72, pages 92-103.
Crossref
Crossref
Cheril L. Clarson, Hilary K. Brown, Stefanie De Jesus, Michelle Jackman, Farid H. Mahmud, Harry Prapavessis, Tracy Robinson, J. Kevin Shoemaker, Margaret Watson, A. Justine Dowd & David J. Hill. (2014) Effects of a Comprehensive, Intensive Lifestyle Intervention Combined with Metformin Extended Release in Obese Adolescents. International Scholarly Research Notices 2014, pages 1-13.
Crossref
Crossref
Yaser T. Bazargani, Anthonius de Boer, Hubert G. M. Leufkens & Aukje K. Mantel-Teeuwisse. (2014) Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists. PLoS ONE 9:9, pages e106072.
Crossref
Crossref
Hsin-Yi Lo, Chien-Yun Hsiang, Tsai-Chung Li, Chia-Cheng Li, Hui-Chi Huang, Jaw-Chyun Chen & Tin-Yun Ho. (2014) A Novel Glycated Hemoglobin A1c-Lowering Traditional Chinese Medicinal Formula, Identified by Translational Medicine Study. PLoS ONE 9:8, pages e104650.
Crossref
Crossref
Fu-Sheng Fang, Yan-Ping Gong, Chun-Lin Li, Jian Li, Hui Tian, Wei Huang, Liang-Chen Wang & Lin Li. (2014) Comparison of repaglinide and metformin monotherapy as an initial therapy in Chinese patients with newly diagnosed type 2 diabetes mellitus. European Journal of Endocrinology 170:6, pages 901-908.
Crossref
Crossref
L. Pala & C. M. Rotella. (2014) The “slower” the better. Journal of Endocrinological Investigation 37:5, pages 497-498.
Crossref
Crossref
Minjie Lin, Shuiping Zhao, Li Shen & Danyan Xu. (2014) Potential Approaches to Ameliorate Hepatic Fat Accumulation Seen with MTP Inhibition. Drug Safety 37:4, pages 213-224.
Crossref
Crossref
Mario M. LeitaoJr.Jr. & Richard R. Barakat. 2014. Fundamentals of Cancer Prevention. Fundamentals of Cancer Prevention
593
611
.
Michael R. Rickels, Melena Bellin, Frederico G.S. Toledo, R. Paul Robertson, Dana K. Andersen, Suresh T. Chari, Randall Brand, Luca Frulloni, Michelle A. Anderson & David C. Whitcomb. (2013) Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: Recommendations from PancreasFest 2012. Pancreatology 13:4, pages 336-342.
Crossref
Crossref
Sercan Aksoy, Mehmet Ali Nahit Sendur & Kadri Altundag. (2013) Demographic and clinico-pathological characteristics in patients with invasive breast cancer receiving metformin. Medical Oncology 30:2.
Crossref
Crossref
Mary Elizabeth Cox & Mark N. Feinglos. (2013) Risk vs Benefit in Diabetes Pharmacotherapy: a Rational Approach to Choosing Pharmacotherapy in Type 2 Diabetes. Current Diabetes Reports 13:3, pages 319-328.
Crossref
Crossref
Brendan C. MacGillivray & Donal H. Macartney. (2013) Cucurbit[7]uril Host–Guest Complexes with Biguanidinium Cations in Aqueous Solution. European Journal of Organic Chemistry 2013:13, pages 2573-2582.
Crossref
Crossref
Jia Xiao, Rui Guo, Man Lung Fung, Emily C Liong & George L Tipoe. (2013) Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges. Hepatobiliary & Pancreatic Diseases International 12:2, pages 125-135.
Crossref
Crossref
Isma Haq, Alvaro GARCIA CRUZ, Sabrina Di Masi, Todd Cowen, Natalie S. Allcock, Cosimino Malitesta, Adnan Mujahid, Tajamal Hussain, Elena Piletska & Sergey A. Piletsky. (2022) Smart Nano-Actuators for Electrochemical Sensing of Metformin in Human Plasma. SSRN Electronic Journal.
Crossref
Crossref